Retinoid receptors in human lung cancer and breast cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 350, Issue 1, 1996, Pages 267-277

  Zhang, Xiao Kun ^a   Liu, Yi ^a   Lee, Mi Ock ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Carcinogenesis; Chemoprevention; Malignancy; Retinoic acid; Retinoic acid receptor ; Retinoid resistance

Indexed keywords

ALITRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID;

BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL;

EID: 0030026034     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(95)00102-6     Document Type: Conference Paper

References (88)

1. Lotan, R. Effect of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim. Biophys. Acta 605: 33-91, 1981.
2. Roberts, A.B. and Sporn, M.B. Cellular biology and biochemistry of the retinoids. In: M.B. Sporn, A.B. Roberts and D.S. Goodman (Eds.), The Retinoids, Vol. 2, pp. 209-286, Academic Press, Florida, 1984.
3. Lippman, S.M., Kessler, J.F. and Meyskens, F.L. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat. Rep. 71: 493-405 (Part 1); 493-515 (Part 2), 1987.
4. Lippman, S.M., Kessler, J.F. and Meyskens, F.L. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat. Rep. 71: 493-405 (Part 1); 493-515 (Part 2), 1987.
5. Huang, M., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhao, L., Gu, L.J. and Wang, Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988.
6. Castaigne, S., Chomienne, C, Daniel, M.T., Ballerini, P., Berger, R., Fenaur, P. and Degos, L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704-1709, 1990.
7. Chomienne, C., Ballerini, P., Balitrand, N., Amar, M., Bernard, J.F., Boivin, P., Daniel, M.T., Berger, R., Castaigenes and Degos, L. Retinoic acid therapy for promyelocytic leukemia. Lancet ii: 746, 1989.
8. Warrell, R.P. Jr., Frankel, S.R., Miller, W.H., Jr., Scheinberg, D.A., Itri, L.M., Hittelmen, W.N., Vyas, R., Andereff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M., Dmitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324: 1385, 1991.
9. Lippman, S., Kavanagh, J., Paredes-Espinoza, M. et al. 13-cis-retinoic acid plus interferon-alpha-2a: highly active systematic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst. 84: 241-245, 1992.
10. Lippman, S., Parkinson, D., Itri, L. et al. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl. Cancer Inst. 84: 235-241, 1992.
11. Hong, W.K. et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315: 1501-1505, 1986.
12. Hong, W.K., Lippman, S.M., Itri, L.M., Karp, D., Lee, J.S., Byers, R., Schantz, S.P., Kramer, A.M., Lotan, R., Peters, L.J., Dimery, I.W., Brown, W.B. and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323: 795-801, 1990.
13. Mettlin, C. Graham, S., Swanson, M. Vitamin A and lung cancer. J. Natl. Cancer Inst. 62: 1435-1438, 1979.
14. Shekelle, R.B., Liu, S., Raynor, W.R. Jr., Lepper, M., Maliza, C., Rosof, A.H., Paul, O., Shyrock, A.M. and Stamler, J. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet ii: 1185-1189, 1981.
15. Kard, J.D., Smith, A.H., Switzer, B.R. and Hanes, C.G. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J. Natl. Cancer Inst. 66: 7-16, 1981.
16. Gerber, M., Cavallo, F., Marubini, E., Richardson, S., Barbieri, A., Capitelli, E., Costa, A., Crastes de Paulet, A., Crastes de Paulet, P., Decarli, A., Pastorino, U. and Pujol, H. Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern France. Int. J. Cancer 42, 489-494, 1988.
17. Lansnitzki, I. and Bollag, W. Prevention and reversal by a retinoid of 3,4-benzpyrene- and cigarette smoke condensate-induced hyperplasia and metaplasia of rodent respiratory epithelia in organ culture. Cancer Treat. Rep. 66: 1375-1380, 1982.
18. Saffiotti, U., Montesano, R., Sellakumar, A.R. and Borg, S.A. Experimental cancer of the lung: inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous tumors. Cancer (Phila.) 20: 857-864, 1967.
19. Moon, R.C. and Mehta, R.G. Chemoprevention of mammary cancer by retinoids. Basic Life Sci. 52, 213-224, 1990.
20. Costa, A. Breast cancer chemoprevention. Eur. J. Cancer 29A: 589-592, 1993.
21. Chopra, D.P. Squamous metaplasia in organ cultures of vitamin A-deficiency hamster trachea: cytokinetics and ultrastructural alteration. J. Natl. Cancer Inst. 69: 895-901, 1982.
22. Gouveia, J., Hercend, T., Lemaigre, G., Mathe, G., Gros, F., Santelli, G., Homasson, J.P., Angebault, M., Lededente, A., Parrot, R., Gaillard, J.P., Bonniot, J.P., Marsac, J. and Pretet, S. Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid. Lancet i: 710-712, 1982.
23. Terasaki, T., Shimosato, Y., Nakajima, T., Tsumuraya, M., Ichinose, H., Nagatsu, T. and Kato, K. Reversible squamous cell characteristics induced by vitamin A deficiency in a small cell lung cancer cell line. Cancer Res. 47: 3533-3577, 1987.
24. Doyle, L.A., Giangiulo, D., Hussain, A., Park, H-J., Chiu Yen, R-W and Boeges, M. Differentiation of human variant small cell lung cancer cells lines to a classic morphology by retinoic acid. Cancer Res., 49: 6745-6751, 1989.
25. Saccomanno, G., Moran, P.G., Schmidt, R.D. Effects of 13-cis retinoids on premalignant and malignant cells of lung origin. Acta Cytol. 26: 78-85, 1982.
26. Marth, C., Bock, G. and Daxenbichler, G. Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst. 75: 871-875, 1985.
27. Wetherall, N.T. and Taylor, C.M. The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. Eur. J. Cancer Clin. Oncol. 22: 53-59, 1986.
28. Fontana, J.A. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell. Biol. 55: 136-144, 1987.
29. Fontana, J.A., Hobbs, P.D. and Dawson, M.I. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp. Cell. Biol. 56: 254-263, 1988.
30. Fontana, J.A., Mezu, A.B., Cooper, B.N. and Miranda, D. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res. 50: 1997-2002, 1990.
31. Koga, M. and Sutherland, R.L. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antiestrogen to inhibit human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol. 39: 455-460, 1991.
32. Fontana, J.A. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation [1]. Expl. Cell. Biol. 55: 136-144, 1987.
33. Fontana, J.A., Mezu, A.B., Cooper, B.N. and Miranda, D. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells [1]. Cancer Res. 50: 1997-2002, 1990.
34. Koga, M. and Sutherland, R.L. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol. 39: 455-460, 1991.
35. Butler, W.B. and Fontana, J.A. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7 [1]. Cancer Res. 52: 6164-6167, 1992.
36. Modiano, M., Dalton, W., Lippman, S. et al. Phase II study of fenretinide (n-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest. New Drugs 8: 317-319, 1990.
37. Cassidy, J., Lippman, M., LaCroix, A. et al. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer. Eur. J. Cancer Clin. Oncol. 18: 925-928, 1982.
38. Goodman, G. Phase II trial of retinol in patients with advanced cancer. Cancer Treat. Rep. 70: 1023-1024, 1986.
39. Grunberg, S., Itri, L. Phase II study of isotretinoin in the treatment of advanced nonsmall cell lung cancer. Cancer Treat. Rep. 71: 1097-1098, 1987.
40. Petkovich, M., Brand, N.J., Krust, A. and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444-450, 1987.
41. Giguere, V., Ong, E.S., Seigi, P. and Evans, R.M. Identification of a receptor for the morphogen retinoic acid. Nature 330: 624-629, 1987.
42. Benbrook, D., Lernhardt, E. and Pfahl. M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333: 624-629, 1988.
43. Brand, N., Petkovich, M., Krust, A., de The, H., Marchio, A., Tiollais, P. and Dejean, A. Identification of a second human retinoic acid receptor. Nature 332: 850-853, 1988.
44. Krust, A., Kastner, P.H., Petkovich, M., Zelent, A. and Chambon, P. A third human retinoic acid receptor, hRARg. Proc. Natl. Acad. Sci USA 86: 5310-5314, 1989.
45. Giguere, V., Shago, M., Zirngibl. R., Tate, J.P., Rossant, J. and Varmuza, S. Identification of a novel isoform of the retinoic acid receptor g expressed in the mouse embryo. Mol. Cell. Biol. 10: 2335-2340, 1990.
46. Hamada, K., Gleason, S.L., Levi, B.Z., Hirschfeld, S., Appella, E. and Ozato, K. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA 86: 8289-8293, 1989.
47. Mangelsdorf, D.J., Ong, E.S., Dyck, J.A. and Evans, R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229, 1990.
48. Yu, V.C., Delsert, C., Andersen, B., Holloway, J.M., Devary, O.V. Naar, A.M., Kim, S.Y., Boutin, J-M., Glass, C.K. and Rosenfeld, M.G. RXRb: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991.
49. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J-Y., Staub, A., Garnier, J.M., Mader, S. and Chambon, P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395, 1992.
50. Mangelsdorf, D.J., Borgmeyer, U., Heyman, R.A., Zhou, J.Y., Ong, E.S., Oro, A.E., Kakizuka, A. and Evans, R.M. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes Dev. 6: 329-344, 1992.
51. Evans, R.M. The steroid and thyroid hormone receptor family. Science 240: 889-895, 1988.
52. Green, S. and Chambon, P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4: 309-314, 1988.
53. Zhang, X.k., Hoffmann, B., Tran, P., Graupner, G. and Pfahl, M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-446, 1992.
54. Kliewer, S.A., Umesono, K., Mangelsdorf, D.L. and Evans, R.M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature 355: 446-449, 1992.
55. Marks, M.S., Hallenbeck, P.L., Nagata, T., Segars, J.H., Apella, E., Nikodem, V.M. and Ozato, K. H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J. 11: 1419-1435, 1992.
56. Bugge, T.H., Pohl, J. Lonnoy, O. and Stunnenberg, H.G. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 11: 1409-1418, 1992.
57. Zhang, X.-k. and Pfahl, M. Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol. Metab. 4: 156-162, 1993.
58. de The, H., Vivanco-Ruiz, M.M., Tiollais, P., Stunnenberg, H. and Dejean, A. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343: 177-180, 1990.
59. Sucov, H.M., Murakami, K.K. and Evans, R.M. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc. Natl. Acad. Sci. USA 87: 5392-5396, 1990.
60. Hoffmann, B., Lehmann, J.M., Zhang, X-k., Hermann, T., Graupner, G. and Pfahl, M. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol. Endocrinol. 4: 1734-1743, 1990.
61. de The, Marchio, A., Tiollias, P. and Dejean, A. Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J. 8: 429-433, 1989.
62. Haq, R.U., Pfahl, M. and Chytil, F. Retinoic acid affects the expression of nuclear retinoic acid receptors in tissues of retinol deficient rats. Proc. Natl. Acad. Sci. USA 88: 8272-8276, 1991.
63. Zhang, X.-k., Liu, Y., Lee, M-O. and Pfahl. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54: 5663-5669, 1994.
64. Nervi, C., Volleberg, T.M., George, M.D., Zelent, A., Chambon, P. and Jetten, A.M. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res. 195: 163-170, 1991.
65. Houle, B., Leduc, F. and Bradley, W.E.C. Implication of RARb in epidermoid (squamous) lung cancer. Genes, Chr. Cancer 3:358-366, 1991.
66. Gebert, J.F., Moghal, N., Frangioni, J.V., Sugarbaker, D.J. and Neel, B.G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 6: 1859-1868, 1991.
67. Geradts, J., Chen, J.Y., Russell, E.K., Yankaskas, J.R., Nieves, L. and Minna, J.D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ. 4: 799-809, 1993.
68. Roman, S.D., Clarke, C.L., Hall, R.E., Alexander, I.E. and Sutherland, R.L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52: 2236-2242, 1992.
69. van der Burg, B., van der Leede, B-j. M., Kwakkenbox-Isbrucker, L., Salverda, S., de Laat, S.W. and van der Saag, P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 91: 149-157, 1993.
70. Sheikh, M.S., Shao, Z.M., Chen, J.C., Hussain. A., Jetten, A.M. and Fontana, J.A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell Biochem. 53: 393-404, 1993.
71. Yang-Yen, H.F., Zhang, X-k., Graupner, G., Tzukerman, M. Sakamoto, B., Karin, M. and Pfahl, M. Antagonism between retinoic acid receptors and AP-1: Implications for tumor promotion and inflammation. New Biol. 3: 1206-1219, 1991.
72. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L.J., Bolado, J., Verma, I.M. and Evans, R.M. Retinoic acid is a negative regulator of AP-1 responsive genes. Proc. Natl. Acad. Sci. USA 88: 6092-6096, 1991.
73. Borrow, J., Goddard, A.D., Sheer, D. and Sonomon, E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249: 1577-1580, 1990.
74. Alcalay, M., Zangrilli, D., Pandolfi, P.P., Longo, L., Mencarelli, A., Giacomucci, A., Rocchi, M., Biondi, A., Rambaldi, A., Lo Coco, F., Diverio, D., Donti, E., Grignani, F. and Pelicci, P.G. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proc. Natl. Acad. Sci. USA 88: 1977-1981, 1991.
75. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. The PML-RARα fusion mRNA generated by the t(15:17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675-684, 1991.
76. Kakizuka, A., Miller, W.H., Jr., Umesono, K., Warrell, R.P., Jr., Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E. and Evans, R.M. Chromosomal translocation t(15:17) in human acute promeylocytic leukemia fuses RARα with a novel putative transcriptional factor, PML. Cell 66: 663-674, 1991.
77. Hu, L., Crowe, D.L., Rheinwald, J.G., Chambon, P. and Gudas, L. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51: 3972-3981, 1991.
78. Bartsch, D., Boye, B., Baust, C., Hausen, H.z and Schwarz, E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11: 2283-2291, 1992.
79. Houle, B., Rochette-Egly, C. and Bradley, W.B.C. Tumor-suppressive effect of the retinoic acid receptor b in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA 90: 985-989, 1993.
80. Damm, K. Thompson, C.C. and Evans, R.M. Protein encoded by v-erbA functions as a thyroid hormone antagonist. Nature 339: 593-597, 1989.
81. Sakurai, A., Takeda, K., Ain, K, Ceccarelli, P., Nakai, A., Seino, S., Bell, G.I., Refetoff, S. and DeGroot, L.J., Generalized resistance to thyroid hormone associated with a mutation in the ligand binding domain of the human thyroid hormone receptor β. Proc. Natl. Acad. Sci. USA 86: 8977-8981, 1989.
82. Pratt, M.A.C., Kralova, J. and McBurney, M.W. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol. Cell. Biol. 10: 6445-6453, 1990.
83. Gallagher, R.E., Said, F., Pua, I. Papenhausen, P.R., Paietta, E., Wiernik, P.H. Expression of retinoic acid receptor a-mRNA in human leukemia cells with variable responsiveness to retinoic acid. Leukemia 3: 789, 1990.
84. Largment, C. Detmer, K., Corral, J.C., Hack, F.M., Lawrence J. Expression of retinoic acid receptor alpha mRNA in human leukemia cells. Blood 74: 99, 1989.
85. Wang, C. Curtis, J.E., Minden, M.D., McCulloch, E.A., Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 264: 1989.
86. Clifford, E.A., Petkovich, M., Chambon, P., Lotan, R. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol. Endocrinol. 4: 1546, 1990.
87. Berkenstam, A. et al. Cooperativity in transcription between retinoic acid receptor and TFIID requires an activity analogous to E1A. Cell 69: 401-412, 1992.
88. Kruyt, F.A.E., et al. E1a functions as a coactivator of retinoic acid-dependent retinoic acid receptor-b2 promoter activation. Mol. Endocrinol. 7: 604-615, 1993.